It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Novel methods to characterize the plasma proteome has made it possible to examine a wide range of proteins in large longitudinal cohort studies, but the complexity of the human proteome makes it difficult to identify robust protein-disease associations. Nevertheless, identification of individuals at high risk of early mortality is a central issue in clinical decision making and novel biomarkers may be useful to improve risk stratification. With adjustment for established risk factors, we examined the associations between 138 plasma proteins measured using two proximity extension assays and long-term risk of all-cause mortality in 3,918 participants of the population-based Malmö Diet and Cancer Study. To examine the reproducibility of protein-mortality associations we used a two-step random-split approach to simulate a discovery and replication cohort and conducted analyses using four different methods: Cox regression, stepwise Cox regression, Lasso-Cox regression, and random survival forest (RSF). In the total study population, we identified eight proteins that associated with all-cause mortality after adjustment for established risk factors and with Bonferroni correction for multiple testing. In the two-step analyses, the number of proteins selected for model inclusion in both random samples ranged from 6 to 21 depending on the method used. However, only three proteins were consistently included in both samples across all four methods (growth/differentiation factor-15 (GDF-15), N-terminal pro-B-type natriuretic peptide, and epididymal secretory protein E4). Using the total study population, the C-statistic for a model including established risk factors was 0.7222 and increased to 0.7284 with inclusion of the most predictive protein (GDF-15; P < 0.0001). All multiple protein models showed additional improvement in the C-statistic compared to the single protein model (all P < 0.0001). We identified several plasma proteins associated with increased risk of all-cause mortality independently of established risk factors. Further investigation into the putatively causal role of these proteins for longevity is needed. In addition, the examined methods for identifying multiple proteins showed tendencies for overfitting by including several putatively false positive findings. Thus, the reproducibility of findings using such approaches may be limited.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Lund University, Diabetes and Cardiovascular Disease—Genetic Epidemiology, Department of Clinical Sciences in Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
2 Lund University, Diabetes and Cardiovascular Disease—Genetic Epidemiology, Department of Clinical Sciences in Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); College of Medicine Qatar University, Department of Population Medicine, Doha, Qatar (GRID:grid.412603.2) (ISNI:0000 0004 0634 1084)
3 Lund University, Diabetes and Cardiovascular Disease—Genetic Epidemiology, Department of Clinical Sciences in Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361); Lund University, Hypertension and Cardiovascular Disease, Department of Clinical Sciences in Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
4 Lund University, Cardiovascular Epidemiology, Department of Clinical Sciences in Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
5 Lund University, Experimental Cardiovascular Research, Department of Clinical Sciences in Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
6 Lund University, Hypertension and Cardiovascular Disease, Department of Clinical Sciences in Malmö, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)